The impact of mgrA on progression of Staphylococcus aureus sepsis
- 1 June 2014
- journal article
- Published by Elsevier in Microbial Pathogenesis
- Vol. 71-72, 56-61
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistanceInternational Journal of Antimicrobial Agents, 2012
- Basis of Virulence in Community-Associated Methicillin-ResistantStaphylococcus aureusAnnual Review of Microbiology, 2010
- Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemiaBMC Microbiology, 2008
- NorC, a New Efflux Pump Regulated by MgrA of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2006
- mgr, a Novel Global Regulator inStaphylococcus aureusJournal of Bacteriology, 2003
- The Epidemiology of Sepsis in the United States from 1979 through 2000New England Journal of Medicine, 2003
- Regulation of virulence determinants in Staphylococcus aureusInternational Journal of Medical Microbiology, 2001
- Staphylococcus aureusInfectionsNew England Journal of Medicine, 1998
- Staphylococcus aureus: A Well–Armed PathogenClinical Infectious Diseases, 1998
- T lymphocytes from the normal human peritoneum contain high frequencies of Th2‐type CD8+ T cellsEuropean Journal of Immunology, 1996